These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9561030)

  • 1. Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade.
    Brasch RC; Daldrup H; Shames D; Wendland M; Okuhata Y; Rosenau W
    Acad Radiol; 1998 Apr; 5 Suppl 1():S2-5. PubMed ID: 9561030
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
    Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
    AJR Am J Roentgenol; 1998 Oct; 171(4):941-9. PubMed ID: 9762973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
    Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
    Pediatr Radiol; 1998 Feb; 28(2):67-78. PubMed ID: 9472047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model.
    Turetschek K; Roberts TP; Floyd E; Preda A; Novikov V; Shames DM; Carter WO; Brasch RC
    J Magn Reson Imaging; 2001 Jun; 13(6):882-8. PubMed ID: 11382948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.
    Turetschek K; Huber S; Floyd E; Helbich T; Roberts TP; Shames DM; Tarlo KS; Wendland MF; Brasch RC
    Radiology; 2001 Feb; 218(2):562-9. PubMed ID: 11161179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying tumor vascular permeability heterogeneity with magnetic resonance imaging contrast agents.
    Aref M; Brechbiel M; Wiener EC
    Invest Radiol; 2002 Apr; 37(4):178-92. PubMed ID: 11923640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial mapping of microvascular permeability and tissue blood volume using magnetic resonance imaging.
    Demsar F; Roberts TP; Schwickert HC; Shames DM; van Dijke CF; Mann JS; Saeed M; Brasch RC
    Acad Radiol; 1996 Aug; 3 Suppl 2():S344-6. PubMed ID: 8796599
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation.
    Cohen FM; Kuwatsuru R; Shames DM; Neuder M; Mann JS; Vexler V; Rosenau W; Brasch RC
    Invest Radiol; 1994 Nov; 29(11):970-7. PubMed ID: 7890512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas.
    Brasch RC; Shames DM; Cohen FM; Kuwatsuru R; Neuder M; Mann JS; Vexler V; Mühler A; Rosenau W
    Invest Radiol; 1994 Jun; 29 Suppl 2():S8-11. PubMed ID: 7928277
    [No Abstract]   [Full Text] [Related]  

  • 10. Time and dose dependency of radiation-induced changes in tumor microvascular characteristics using contrast-enhanced magnetic resonance imaging: impact on the delivery of chemotherapeutic agents.
    Schmidt HC; Brasch RC; Roberts TP; Shames DM; van Dijke CF; Stiskal M; Mann JS; Mühler A; Demsar F
    Acad Radiol; 1996 Aug; 3 Suppl 2():S347-8. PubMed ID: 8796600
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging.
    Daldrup-Link HE; Shames DM; Wendland M; Mühler A; Gossmann A; Rosenau W; Brasch RC
    Acad Radiol; 2000 Nov; 7(11):934-44. PubMed ID: 11089696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.
    van Dijke CF; Brasch RC; Roberts TP; Weidner N; Mathur A; Shames DM; Mann JS; Demsar F; Lang P; Schwickert HC
    Radiology; 1996 Mar; 198(3):813-8. PubMed ID: 8628876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of peritumoral vessels with contrast-enhanced magnetic resonance imaging: comparison of gadopentetate dimeglumine and a blood-pool macromolecular contrast medium.
    Brasch RC; Schwickert HC; Roberts TP; Shames DM; van Dijke CF; Mann JS; Demsar F
    Acad Radiol; 1996 Aug; 3 Suppl 2():S464-5. PubMed ID: 8796630
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor blood volume assays using contrast-enhanced magnetic resonance imaging: regional heterogeneity and postmortem artifacts.
    Okuhata Y; Brasch RC; Pham CD; Daldrup H; Wendland MF; Shames DM; Roberts TP
    J Magn Reson Imaging; 1999 May; 9(5):685-90. PubMed ID: 10331764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents.
    Su MY; Wang Z; Carpenter PM; Lao X; Mühler A; Nalcioglu O
    J Magn Reson Imaging; 1999 Feb; 9(2):177-86. PubMed ID: 10077011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.
    Turetschek K; Floyd E; Helbich T; Roberts TP; Shames DM; Wendland MF; Carter WO; Brasch RC
    J Magn Reson Imaging; 2001 Sep; 14(3):237-42. PubMed ID: 11536400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods.
    Helbich TH; Roberts TP; Gossmann A; Wendland MF; Shames DM; Adachi M; Yang S; Huber S; Daldrup H; Brasch RC
    Magn Reson Med; 2000 Dec; 44(6):915-24. PubMed ID: 11108629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI.
    Wang Z; Su MY; Najafi A; Nalcioglu O
    Magn Reson Imaging; 2001 Oct; 19(8):1063-72. PubMed ID: 11711230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution.
    Demsar F; Roberts TP; Schwickert HC; Shames DM; van Dijke CF; Mann JS; Saeed M; Brasch RC
    Magn Reson Med; 1997 Feb; 37(2):236-42. PubMed ID: 9001148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.